Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.

Mast cells are effector cells known to contribute to allergic airway disease. When activated, mast cells release a broad spectrum of inflammatory mediators, including the mast cell-specific protease carboxypeptidase A3 (CPA3). The expression of CPA3 in the airway epithelium and lumen of asthma patie...

Full description

Bibliographic Details
Main Authors: Ida Waern, Srinivas Akula, Venkata Sita Rama Raju Allam, Sowsan Taha, Thorsten B Feyerabend, Magnus Åbrink, Sara Wernersson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0300668&type=printable
_version_ 1827278390429745152
author Ida Waern
Srinivas Akula
Venkata Sita Rama Raju Allam
Sowsan Taha
Thorsten B Feyerabend
Magnus Åbrink
Sara Wernersson
author_facet Ida Waern
Srinivas Akula
Venkata Sita Rama Raju Allam
Sowsan Taha
Thorsten B Feyerabend
Magnus Åbrink
Sara Wernersson
author_sort Ida Waern
collection DOAJ
description Mast cells are effector cells known to contribute to allergic airway disease. When activated, mast cells release a broad spectrum of inflammatory mediators, including the mast cell-specific protease carboxypeptidase A3 (CPA3). The expression of CPA3 in the airway epithelium and lumen of asthma patients has been associated with a Th2-driven airway inflammation. However, the role of CPA3 in asthma is unclear and therefore, the aim of this study was to investigate the impact of CPA3 for the development and severity of allergic airway inflammation using knockout mice with a deletion in the Cpa3 gene. We used the ovalbumin (OVA)- and house-dust mite (HDM) induced murine asthma models, and monitored development of allergic airway inflammation. In the OVA model, mice were sensitized with OVA intraperitoneally at seven time points and challenged intranasally (i.n.) with OVA three times. HDM-treated mice were challenged i.n. twice weekly for three weeks. Both asthma protocols resulted in elevated airway hyperresponsiveness, increased number of eosinophils in bronchoalveolar lavage fluid, increased peribronchial mast cell degranulation, goblet cell hyperplasia, thickening of airway smooth muscle layer, increased expression of IL-33 and increased production of allergen-specific IgE in allergen-exposed mice as compared to mocktreated mice. However, increased number of peribronchial mast cells was only seen in the HDM asthma model. The asthma-like responses in Cpa3-/- mice were similar as in wild type mice, regardless of the asthma protocol used. Our results demonstrated that the absence of a functional Cpa3 gene had no effect on several symptoms of asthma in two different mouse models. This suggest that CPA3 is dispensable for development of allergic airway inflammation in acute models of asthma in mice.
first_indexed 2024-04-24T07:57:06Z
format Article
id doaj.art-5d422de2ddd544e69e4723f4b0b86f17
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-24T07:57:06Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5d422de2ddd544e69e4723f4b0b86f172024-04-18T05:31:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01194e030066810.1371/journal.pone.0300668Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.Ida WaernSrinivas AkulaVenkata Sita Rama Raju AllamSowsan TahaThorsten B FeyerabendMagnus ÅbrinkSara WernerssonMast cells are effector cells known to contribute to allergic airway disease. When activated, mast cells release a broad spectrum of inflammatory mediators, including the mast cell-specific protease carboxypeptidase A3 (CPA3). The expression of CPA3 in the airway epithelium and lumen of asthma patients has been associated with a Th2-driven airway inflammation. However, the role of CPA3 in asthma is unclear and therefore, the aim of this study was to investigate the impact of CPA3 for the development and severity of allergic airway inflammation using knockout mice with a deletion in the Cpa3 gene. We used the ovalbumin (OVA)- and house-dust mite (HDM) induced murine asthma models, and monitored development of allergic airway inflammation. In the OVA model, mice were sensitized with OVA intraperitoneally at seven time points and challenged intranasally (i.n.) with OVA three times. HDM-treated mice were challenged i.n. twice weekly for three weeks. Both asthma protocols resulted in elevated airway hyperresponsiveness, increased number of eosinophils in bronchoalveolar lavage fluid, increased peribronchial mast cell degranulation, goblet cell hyperplasia, thickening of airway smooth muscle layer, increased expression of IL-33 and increased production of allergen-specific IgE in allergen-exposed mice as compared to mocktreated mice. However, increased number of peribronchial mast cells was only seen in the HDM asthma model. The asthma-like responses in Cpa3-/- mice were similar as in wild type mice, regardless of the asthma protocol used. Our results demonstrated that the absence of a functional Cpa3 gene had no effect on several symptoms of asthma in two different mouse models. This suggest that CPA3 is dispensable for development of allergic airway inflammation in acute models of asthma in mice.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0300668&type=printable
spellingShingle Ida Waern
Srinivas Akula
Venkata Sita Rama Raju Allam
Sowsan Taha
Thorsten B Feyerabend
Magnus Åbrink
Sara Wernersson
Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
PLoS ONE
title Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
title_full Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
title_fullStr Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
title_full_unstemmed Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
title_short Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
title_sort disruption of the mast cell carboxypeptidase a3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0300668&type=printable
work_keys_str_mv AT idawaern disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma
AT srinivasakula disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma
AT venkatasitaramarajuallam disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma
AT sowsantaha disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma
AT thorstenbfeyerabend disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma
AT magnusabrink disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma
AT sarawernersson disruptionofthemastcellcarboxypeptidasea3genedoesnotattenuateairwayinflammationandhyperresponsivenessintwomousemodelsofasthma